	Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment? Med Res Rev Fonseca LRS, Feijó M, Vaz CV, Pereira BJ, Laurentino S, Palmeira-de-Oliveira A, Socorro S. PMID: 41943884 [PubMed - as supplied by publisher]
	Metabolic-Immune Coupling in Urologic Cancers: Macrophage Reprogramming as a Therapeutic Nexus. Int J Biol Sci Huang W, Li W, Shangguan W, Yang L, Li Z, Sun B, Ma C, Yang X, Peng P, Zhao J, Cheng B, Wu P. PMID: 41943838 [PubMed - indexed for MEDLINE]
	Oncological Safety of Testosterone Replacement Therapy in Men With a History of Prostate Cancer: A Systematic Review. Cureus Alexandre Alves VA, Brasileiro Silva AA, Falcao Bisneto EL, Macedo HF, Lima GS, Santos De Souza LGP, Barbosa PEA, Medeiros Júnior PF. PMID: 41943753 [PubMed]
	Risk Factors and Predictive Model for Peripherally Inserted Central Catheter Tip Migration in Patients With Bladder Cancer. Arch Esp Urol Zheng K, Cui X, Liu Y, Du M, Yang G. PMID: 41943705 [PubMed - indexed for MEDLINE]
	Clinical and Pathological Features of Renal Cell Carcinoma in Young Adults. Arch Esp Urol Öztürk A, Kaya . PMID: 41943694 [PubMed - indexed for MEDLINE]
	Distribution of PD-1.5 Gene Variant (rs2227981): A Possible Approach for Risk Assessment in Bladder Cancer. Arch Esp Urol Kayar K, Verim L, Sonmez D, Kadihasanoglu M, Demirkol S, Kucukhuseyin O, Hakan MT, Lamami Y, Kiran B, Yaylim I. PMID: 41943691 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Keyhole Limpet Hemocyanin in Bacillus Calmette-GuÃ©rin Unresponsive Non-muscle Invasive Bladder Cancer. Arch Esp Urol Chernobilsky V, Gonzalez IT, Favre G. PMID: 41943689 [PubMed - indexed for MEDLINE]
	Advances in Urinary Biomarkers for the Early Detection of Urological Cancers: From Proteins and Epigenetics to Gene Mutations. Arch Esp Urol Li H, Zhang F, Liu X, Wang L. PMID: 41943686 [PubMed - indexed for MEDLINE]
	Multi-Omics Integration in Urological Cancers: Unlocking Precision Diagnosis and Therapy Through Big Data. Arch Esp Urol Delrue C, Speeckaert MM. PMID: 41943684 [PubMed - indexed for MEDLINE]
	Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges. Arch Esp Urol Valencia Nieto P, López-Campos F, Diezhandino García P, Duque-Santana V, Gómez-Aparicio MA, Ocanto A, González de Dueñas M, Maldonado Pijoan X, Shelan M, Álvarez-Maestro M, Couñago F. PMID: 41943683 [PubMed - indexed for MEDLINE]
	Primitive Neuroectodermal Kidney Tumor in Adults. A Systematic Review. Arch Esp Urol Cabello-Gómez E, Rivero-Belenchón I, Congregado-Ruiz CB, Osmán-García I, Medina-López RA. PMID: 41943682 [PubMed - indexed for MEDLINE]
	Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence. Technol Cancer Res Treat He JX, Li L, Chen S, Chen RJ, Zhuang JL, Liu C, Burrow W, Chang J, Tanziela T, Bonfil RD, Wong NK, Tao W. PMID: 41943522 [PubMed - indexed for MEDLINE]
	Developing a web-based dashboard for adaptive radiotherapy workflows. J Appl Clin Med Phys DiTusa C, Alexandrian A, Mavroidis P, Sargent E, Allen M, Schneider CW, Stathakis S. PMID: 41942797 [PubMed - indexed for MEDLINE]
	The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients. EMBO Mol Med Bilusic M, Gannamedi DP, Challu B, Ferdous S, Mateo-Victoriano B, Pokharel S, Bayik D, Sharma J, Lombard DB, Rai P. PMID: 41942753 [PubMed - as supplied by publisher]
	Efferocytosis-related gene PLG in prognosis, immune correlation, and contribution to malignant behavior in vitro and in vivo of clear cell renal cell carcinoma. Sci Rep Zhou Y, Zhang Z, Liu Y, Liu W, Dai J. PMID: 41942551 [PubMed - as supplied by publisher]
	Leveraging Population-Level and Multipayer Claims Data to Estimate Changes in Prostate Cancer Screening at the Small-Area Level. JCO Clin Cancer Inform Liang R, Juarez-Colunga E, Perraillon MC. PMID: 41941708 [PubMed - indexed for MEDLINE]
	Identification of Barriers to Digital Patient Portal Adoption Among Patients With Prostate Cancer Undergoing Curative Radiotherapy at a Canadian Provincial Cancer Program: A Quality Improvement Study. JCO Clin Cancer Inform Patil N, Koul R, Moyer J, Kudel I, Beaudry J, Christianson A, Kim JO. PMID: 41941707 [PubMed - indexed for MEDLINE]
	Digital UromonitorÂ® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club UrolÃ³gico EspaÃ±ol de Tratamiento OncolÃ³gico Group' (EVALUATION-CUETO) study. BJU Int Rubio-Briones J, Guerrero Ramos F, Mercadé Sánchez A, Bezana Abadía I, Martín Rodríguez R, Alcaraz A, Miqueleiz Legaz M, Lozano F, Arrabal Martín M, Luis Cardo A, Gonzalo Rodríguez V, Caño Velasco J, Serrano Liesa M, Ferreiro Pareja C, Espílez Ortiz R, González-Valcárcel de Torres I, Sánchez Zalabardo D, Guijarro A, Mengual L, Borque-Fernando A, Esteban Escaño LM, Palou Redorta J, Witjes F, Martínez Piñeiro L. PMID: 41941336 [PubMed - as supplied by publisher]
	Mediation analysis of adherence to pelvic floor muscle training and weekly self-monitoring on urinary symptoms in men with localized prostate cancer: A secondary analysis of the Prostate Cancer-Patient Empowerment Program (PC-PEP) randomized controlled trial. Can Urol Assoc J Chedrawe E, Smith NK, Ilie G, Rendon RA, Mason R, Kokorovic A, MacDonald C, Patil N, Bowes D, Bailly G, Abou-Samra E, Bourne A, Hagerman LP, Rutledge R. PMID: 41941257 [PubMed - as supplied by publisher]
	Progress in management of advanced clear-cell renal cell carcinoma. Clin Transl Oncol Zhang L, Wang J, Hu J, Yao J. PMID: 41941086 [PubMed - as supplied by publisher]

Articles 1 - 20 / 177310

Page 1 of 8866



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy